1Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmuller A,Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29:1423-1430.
2Xie H, Ji D, Gong D, Liu Y, Xu B, Zhou H, Liu Z, Li L, Li W,Quan Z, Li J. Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin J Med 2003; 116:549-553.
3Yekebas EF, Strate T, Zolmajd S, Eisenberger CF, Erbersdobler A, Saalmuller A, Steffani K, Busch C, Eisner HA, Engelhardt M, Gillesen A, Meins J, The M, Knoefel WT, Izbicki JR. Impactof different modalities of continuous veno-venous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 2002; 62:1806-1818.
5Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 25:733-747.
6De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, DeSutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10:846-853.
7Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ.Pinsky MR. Diffusive vs convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26:1995-2000.
8Tetta C, Mariano F, Buades J, Ronco C, Wratten ML, Camussi G. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. Am J Kidney Dis 1997; 30 (5 Suppl 4): $57-65.
9Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high vlume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004;50:102-109.
10Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N,Camps B, Vina J, Sastre J. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy 2002; 1[:393-403.
10Hans G. Beger M.D., F.A.C.S.,Markus Büchler M.D.,Reinhard Bittner M.D.,Wolfgang Oettinger M.D.,Silvia Block M.D.,Timo Nevalainen M.D.. Necrosectomy and postoperative local lavage in patients with necrotizing pancreatitis: Results of a prospective clinical trial[J] 1988,World Journal of Surgery(2):255～261
